Journal Logo

Articles by J.-C. Eisenmann

IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA TRANSPLANT-ELIGIBLE PATIENTS TREATED WITH DARATUMUMAB, BORTEZOMIB, THALIDOMIDE, AND DEXAMETHASONE: CASSIOPEIA STUDY: PS1377

Roussel, M.; Moreau, P.; Attal, M.; More

HemaSphere. 3:630, June 2019.